Toby Page trained at the Royal Free Medical School in London, where he was awarded a first class Bachelor of Science (BSc) degree in Clinical Immunology whilst completing his medical Degree (MBBS). He studied for and was awarded a PhD in molecular genetics of renal cancer from the University of Exeter and Plymouth as well as publishing a number of clinical and scientific papers. He moved to the North East in 2005 and is based at the Freeman Hospital on Monday to Thursday.
Specialist interests
His specialist interests are in laser surgery and kidney cancer surgery. He performs laser prostate surgery most weeks and is trained in the use of both holmium and high power green light (KTP) lasers. He is also training surgeons in the safe and effective use of these lasers. He has lectured nationally on prostate surgery and is one of only a few consultant surgeons in the country who can offer treatment for benign prostate surgery with both holmium and KTP lasers, urolift, iTIND as well as saline resection and vaporisation. He also leads the prostate artery embolization service in collaboration with interventional radiology colleagues.
Toby Page performs laparoscopic (keyhole) and open kidney surgery as well as performing donor nephrectomy, where a kidney is removed and transplanted into another person. He currently performs around 50 kidney removal operations a year and his outcome data from this is published publicly via the BAUS website. (http://www.baus.org.uk/patients/surgical_outcomes/neph+outcomes)
Research
His current research interests include assessing the outcomes of treatments for benign prostatic enlargement. He is a senior Honorary Clinical Lecturer at the University of Newcastle medical school and chief investigator for the NIHR PREMISE study comparing TURP vs Rezum vs Urolift vs iTIND in men with troublesome urinary symptoms.
He has presented his work at a number of national and international meetings as well as training surgeons mainly in HOLEP and Nephrectomy.
